2/17/2004

The FDA said it will need an additional 90 days to review whether the morning-after pill should be available over-the-counter because it's concerned about teenagers' use of the product. Advocates of the drug's over-the-counter status say the FDA is responding to political rather than scientific concerns.

Related Summaries